肿瘤易感性基因标志物项目或简称CGEMS是国家肿瘤研究所和哈佛大学的一个合作项目。
The Cancer Genetic Markers of Susceptibility or CGEMS is collaboration between National Cancer Institute and Harvard.
国家肿瘤研究所预测每天出生的女性中的13.2%在她们生命中的某一天将被诊断为乳腺癌。
The National Cancer Institute estimates that at least 13.2 percent of the women born today will be diagnosed with breast cancer at some point in their lives.
据国家肿瘤研究所宣称，该合作的初始动机是希望通过三年的研究确定与前列腺癌和乳腺癌患病风险相关的基因变异。
According to the NCI the initiative "is a three-year study designed to identify common genetic variations associated with risk for prostate and breast cancer."
应用推荐